|Category:||Emerging Biotech Company Presentation|
|Speaker:||Augustin de Bettignies|
MPC Therapeutics is a biotechnology company focused on cellular rejuvenation to fight cancer & degenerative pathologies. Our novel approach uses first-in-class small molecules that induce a metabolic reprogramming by targeting mitochondria. The company is currently focused at improving CAR T therapies against cancer.